Abbott’s Q2 results top estimates, medical device sales up 11%

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jul 18, 2018 at 10:32 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,973
    Likes Received:
    3
    via Abbott (NYSE:ABT) today reported second-quarter results that came in ahead of the consensus expectation, with its medical device division posting sales growth of more than 11%, and raised its earnings outlook for the rest of the year.

    article source